Mariappan. A, Thanalakshmi. J, S. Sundar, Radha S, Meenakumari R, Kaaruniya. G
Mariappan. A1*, Thanalakshmi. J2, S. Sundar3, Radha S4, Meenakumari R5, Kaaruniya. G6
1Associate Professor, Department of Gunapadam, National Institute of Siddha, Chennai.
2Assistant Professor, Department of Physiology, Saveetha Medical College, Chennai.
3Professor, Vijaya Institute of Pharmaceutical Sciences for Women, Vijayawada.
4Medical Consultant, Siddha Clinical Research Unit, Tirupati.
5Director, Professor and Head, Department of Gunapadam, National Institute of Siddha, Chennai.
6Siddha Consultant, Miruthunjai Siddha Clinic, Erode.
Volume - 16,
Issue - 3,
Year - 2023
Aim: The contagious disease COVID 19 is a recently out-broken pandemic situation which threatens humankind all over the world. Siddha system of medicine is one of the traditional medical systems of India, which has provided a novel remedy for many epidemics like Dengue, Chicken guinea earlier. On evaluating the literature evidence and considering the mortality and severity of the disease, we have attempted to identify the possible inhibition of viral replication by "Karisalai Chooranam" - a polyherbal Siddha formulation which contains herbs like Karisalai (Wedelia chinensis), Thoodhuvelai (Solanum trilobatum), Musumusukai (Melothria maderaspatana) and Seeragam (Cuminum cyminum). The aim of this study was to identify the bioactive components present in Karisalai chooranam and pin down the components that inhibit COVID 19 protease by In Silico molecular docking analysis. Material and methods: The study was performed for the active compounds present in the herbs (Wedelia chinensis - Benzoic acid, Solanum trilobatum- Disogenin, Melothria maderaspatana- ß–sitosterol, Cuminum cyminum L- Coumaric acid and Limonene) with three potential targets, PDB id: 6LU7 3-chymotrypsin-like protease (3CLpro), PDB id: 6-NUR RNA dependent RNA polymerase and PDB id: 2AJF Angiotensin-converting enzyme II (ACE2) receptor using Autodock Vina. Key findings: The active phytocomponents present in “Karisalai chooranam” was found to inhibit the target 3CL proenzyme and hereby halt the formation of 16 non-structural proteins (nsp1-nsp16) that are highly essential for viral replication and there by prevents viral survival in the host environment. The phytocomponents also inhibited the target RNA dependent RNA polymerase (PDB)-6NUR RdRp which possess versatile action in mediating nonstructural protein (nsp 12) essential for viral replication. A significant binding against the target Angiotensin-converting enzyme II (ACE2) receptors - PDB- 2AJF was found which was recognized as a binding site for novel coronavirus to cause its pathogenesis. Among the five active components present in the herb, the binding ability of Disogenin and ß–sitosterol with COVID19 protease suggests a possible mechanism of protease inhibition and thus preventing viral replication. Significance: The results strongly suggest that phytocomponents of “Karisalai chooranam” may act as a potential therapeutic agent for the management of COVID-19 and related symptoms. Further, the efficacy of the active compounds should be tested in vitro before being recommended as a drug.
Cite this article:
Mariappan. A, Thanalakshmi. J, S. Sundar, Radha S, Meenakumari R, Kaaruniya. G. In-silico Studies of Active Phytochemicals from Siddha Medicinal Herbs of Karisalai Chooranam against SARS-CoV-2 main Protease (3CLpro), RNA Dependent RNA Polymerase and Angiotensin-Converting Enzyme II Receptor. Research Journal of Pharmacy and Technology 2023; 16(3):1033-0. doi: 10.52711/0974-360X.2023.00173
Mariappan. A, Thanalakshmi. J, S. Sundar, Radha S, Meenakumari R, Kaaruniya. G. In-silico Studies of Active Phytochemicals from Siddha Medicinal Herbs of Karisalai Chooranam against SARS-CoV-2 main Protease (3CLpro), RNA Dependent RNA Polymerase and Angiotensin-Converting Enzyme II Receptor. Research Journal of Pharmacy and Technology 2023; 16(3):1033-0. doi: 10.52711/0974-360X.2023.00173 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-3-9
1. Coronavirus disease 2019. World Health Organization; 15 March 2020.
2. Sarfaraz Ahmad, Ambreen Shoaib, Sajid Ali, Sarfaraz Alam, Nawazish Alam, Maksood Ali, Ali Mujtaba, Ayaz Ahmad, Salahuddin Ansari, Mohammad Daud Ali. Epidemiology, risk, myths, pharmacotherapeutic management and socio economic burden due to novel COVID-19: A recent update. Research J. Pharm. and Tech. 2020; 13(9):4435-4442. doi: 10.5958/0974-360X.2020.00784.2
4. Sonia Mor, Prem Saini, Subhash Kumar Wangnoo, Tarunika Bawa. Worldwide spread of COVID-19 Pandemic and risk factors among Co-morbid conditions especially Diabetes Mellitus in India. Research J. Pharm. and Tech. 2020; 13(5):2530-2532. doi: 10.5958/0974-360X.2020.00450.3
5. Shanmugavelu M. Noi nadal noi mudhal nadal thirattu part-I (in Tamil). 1st ed. Chennai: Directorate of Indian Medicine & Homeopathy; 2014. p. 370
6. Kiran G, Karthik L, Devi MS, Sathiyarajeswaran P, Kanakavalli K, Kumar KM, Kumar DR. In silico computational screening of Kabasura Kudineer-official Siddha formulation and JACOM against SARS-CoV-2 spike protein. Journal of Ayurveda and integrative medicine. 2020 May 25. doi: 10.1016/j.jaim.2020.05.009
7. B. Vinubharathi, V. Mahalakshmi, N. J. Muthukumar, R. Suresh, V. Banumathi. Screening of In vitro Antioxidant Activity of Methanolic extract of Maruthampattai kudineer- A Siddha Polyherbal Preparation. Research J. Pharm. and Tech 2019; 12(1): 219-222. doi: 10.5958/0974-360X.2019.00040.4
8. Samir Derouiche. Current Review on Herbal Pharmaceutical improve immune responses against COVID-19 infection. Res. J. Pharma. Dosage Forms and Tech.2020; 12(3):181-184. doi:10.5958/0975-4377.2020.00031.2
9. Xu Z, Peng C, Y Shi Z, Zhu K, Mu Wang X. Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. BioRxiv. 2020. doi: https://doi.org/10.1101/2020.01.27.921627
10. Adem S, Eyupoglu V, Sarfraz I, Rasul A, Ali M. Identification of Potent COVID-19 Main Protease (Mpro) Inhibitors from Natural Polyphenols: An in Silico Strategy Unveils a Hope against CORONA. MDPI, Preprints 2020; 2020030333. doi: 10.20944/preprints202003.0333.v1
11. Zhu W, Chen CZ, Gorshkov K, Xu M, Lo DC, Zheng W. RNA-dependent RNA polymerase as a target for COVID-19 drug discovery. SLAS DISCOVERY: Advancing the Science of Drug Discovery. 2020 Dec; 25(10):1141-51. doi: 10.1177/2472555220942123
12. Vicenti I, Zazzi M, Saladini F. SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19. Expert Opinion on Therapeutic Patents. 2021 Mar 4:1-3. doi: 10.1080/13543776.2021.1880568
13. Roshanravan N, Ghaffari S, Hedayati M. Angiotensin converting enzyme-2 as therapeutic target in COVID-19. Diabetes and Metabolic Syndrome: Clinical Research & Reviews. 2020 Jul 1; 14(4):637-9. doi: 10.1016/j.dsx.2020.05.022
14. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive care medicine. 2020 Apr; 46(4):586-90. doi: 10.1007/s00134-020-05985-9
15. Vijayalakshmi A, Selvakannan A. Ajith SP. Phytochemical and Physiochemical Standardization of a Siddha Formulation Seenthil Chooranam. Research J. Pharm. and Tech. 2018; 11(1): 23-26. doi: 10.5958/0974-360X.2018.00004.5
16. Jain J, Pai S, Sunil S. Standardization of in vitro assays to evaluate the activity of polyherbal siddha formulations against Chikungunya virus infection. Virus Dis 2018; 29(1):32-39. doi: 10.1007/s13337-018-0421-0.
17. Jain J, Kumar A, Narayanan V, Ramaswamy RS, Sathiyarajeswaran P, Devi MS, et al. Antiviral activity of ethanolic extract of Nilavembu Kudineer against dengue and chikungunya virus through in vitro evaluation. J Ayurveda Integr Med. Jul-Sep 2020;11(3):329-335. doi: 10.1016/j.jaim.2018.05.006.
18. Jain J, Narayanan V, Chaturvedi S, Pai S, Sunil S. In vivo evaluation of withania somniferae based Indian traditional formulation (Amukkara choornam), against chikungunya viruse induced morbidity and arthralgia. J Evid Based Integr Med. 2018 Jan-Dec; 23:2156587218757661. doi: 10.1177/2156587218757661..
19. Shubham Jaiswal, Sarin A. Chavhan, Sushilkumar A. Shinde, N.K. Wawge. New Tools for Herbal Drug Standardization. Asian J. Res. Pharm. Sci. 2018; 8(3): 161-169. doi: 10.5958/2231-5659.2018.00029.2
20. Jasmin Dadras, Nastaran Herman, Sahand Rahimi. The Study of Herbal Medicines and their Therapeutic effects for Farm Animals. Asian J. Pharm. Tech. 2020; 10(3):137-142. doi: 10.5958/2231-5713.2020.00024.0
23. Suraj J. Patil, Shivani D. Patil, Pratibha B. Patil, Pranali S. Patil, Ganesh B. Vambhurkar, Indryani D. Raut. Evaluation of Standardization Parameters of Ayurvedic Marketed Polyherbal Formulation. Asian J. Pharm. Ana. 2018; 8(4): 220-226. doi: 10.5958/2231-5675.2018.00040.6
24. Venkatesan K, Joshi I, Merish S. In-vitro antioxidant activity of a herbal medicine Karisalai Chooranam. Journal of Research in Biomedical Sciences. 2019 Jul 29; 1(2):90-5. doi:10.124583/jrbms.v1i2.35
25. Sulekha S, Reddy GA, Muthuvel A. Physicochemical and phytochemical standardization of polyherbal Siddha formulation ‘Karisalai Chooranam’. Apr 2017. http://nopr.niscair.res.in/handle/123456789/40117
26. H. Rehana Banu. GC-MS determination of bioactive components of Wedelia chinensis (Osbeck) Merrill. Journal of Chemical and Pharmaceutical Research, 2013; 5(4):279-285. https://www.jocpr.com/articles/gcms-determination-of-bioactive-components-of-wedelia-chinensis-osbeck-merrill.pdf
27. Purushothaman Balakrishnan. A perspective on bioactive compounds from Solanum trilobatum. Journal of Chemical and Pharmaceutical Research, 2015; 7(8):507-512. https://www.jocpr.com/articles/a-perspective-on-bioactive-compounds-from-solanum-trilobatum.pdf
28. Deepali Pandey. Pharmacognostical Standardization and Isolation of Ergosterol from Melothria maderaspatana Linn. International Journal of Food Properties .2013; 16(8):1871-1882. doi: 10.1080/10942912.2011.587624
29. Ali Esmail Al-Snafi. The pharmacological activities of Cuminum cyminum - A review. IOSR Journal of Pharmacy. 2016;6(6): 46-65. http://www.iosrphr.org/papers/v6i6V2/G066024665.pdf
30. Bikadi, Z., Hazai, E.Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. J. Cheminf. 2009; 1: 15. doi: 10.1186/1758-2946-1-15
31. Krishnasamy R, Baba M, Bharath MV, Phuntsho J, Arunachalam D, Natarajan K, Ramasamy M. In silico analysis of active compounds from siddha herbal infusion of Ammaiyar Koondhal Kudineer (Akk) against SARS-CoV-2 spike protein and its ACE2 receptor complex. 2020 Apr 17. doi:10.2139/ssrn.3578294
32. ACD/ChemSketch version 12.01, Advanced Chemistry Development, Inc., Toronto, On, Canada, www.acdlabs.com, 2009
33. D.Sivaraman, P.S. Pradeep, S. Sundar Manoharan, C. Ramachandra Bhat, K.V. Leela, V. Venugopal. Revealing potential binding affinity of FDA approved therapeutics targeting Main protease (3CLpro) in impairing novel coronavirus (SARS-CoV-2) replication that causes COVID-19. Coronaviruses. Bentham publisher.2020; 1(1):98-107. doi: 10.2174/2666796701999200701122817
34. T. A. Halgren. Merck molecular force field. I. Basis, form, scope, parametrization, and performance of MMFF94. Journal of Computational Chemistry 1998; 17 (5-6): 490-519. doi:10.1002/(SICI)1096-987X(199604)17:5/6<490: AID-JCC1>3.0.CO;2-P
35. G. M. Morris, D. S. Goodsell, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry 1998; 19 (14): 1639-1662. doi. -10.1002/(SICI)1096-987X(19981115)19:14<1639: AID-JCC10>3.0.CO;2-B
36. F. J. Solis and R. J. B. Wets. Minimization by Random Search Techniques. Mathematics of Operations Research 1981; 6 (1): 19-30. doi -10.1287/moor.6.1.19